Watch: Adrenomed tackling huge issue of sepsis By Jim Cornall December 19, 2022 Adrenomed AG is a German privately financed, clinical-stage biopharmaceutical company. Its mission is to rescue vascular integrity in order to save the
Hennigsdorf/Berlin (Germany), October 13, 2022 – Adrenomed AG, the vascular integrity company, today announced its participation in upcoming industry and investor conferences. The Adrenomed management team will be available for meetings to present and discuss
Hennigsdorf/Berlin (Germany), July 12, 2022 – Adrenomed AG, the vascular integrity company, today announced the appointment of David Germonpré as Chief Financial Officer (CFO) of Adrenomed, effective July 11, 2022. David Germonpré has over 15
“A phenomenal breakthrough is taking shape” An interview with Dr. Rainer Strohmenger, Managing Partner at Wellington Partners (Original interview in German)
Hennigsdorf/Berlin (Germany), June 23, 2022 – Adrenomed AG, the vascular integrity company, today announced the appointment of Dr. med. Steffen Stürzebecher as Chief Medical Officer (CMO) of Adrenomed, effective June 20, 2022. Dr. Stürzebecher is
by Ian Schofield Executive Summary RedHill’s opaganib has shown “potent inhibition” of the Omicron variant in early studies, while the EMA has found nolinks between the mRNA vaccines and autoimmune hepatitis. Read the full
Adrecizumab selected to receive funding from two COVID-19 drug development programs of the German Federal Ministry of Education and Research (BMBF) By restoring vascular integrity, Adrecizumab addresses the endothelial barrier dysfunction as a consequence of
Hennigsdorf/Berlin (Germany), 15 March, 2022 – Adrenomed AG, the vascular integrity company, today announced the appointment of Dr. Richard Jones as Chief Executive Officer of Adrenomed, effective today. Dr. Jones brings over 25 years of
In March, Adrenomed will be attending the 41st International Symposium on Intensive Care & Emergency Medicine, Brussels, Belgium. Conference dates: 22 – 25 March 2022 Additionally, Adrenomed will participate in BIO-Europe Spring (digital) Conference dates:
By loading the map, you agree to Google's privacy policy.
Learn more
© 2024 AdrenoMed AG | Imprint/Impressum | Legal Notice/Datenschutzerklärung | Expanded Access Policy
